Download PDF
Synthesis 2024; 56(11): 1787-1792
DOI: 10.1055/a-2257-0684
paper

A Convenient Method for Synthesizing 1-Alkyl-2-acyl-sn-glycero-3-phosphoethanolamines

Tatsuo Okauchi  ∗
,
Kouta Tsubaki
,
Yuri Higuma
,
Hirokazu Shimooka
,
Mitsuru Kitamura
We gratefully acknowledge financial support for this research from the Institute of Rheological Functions of Food.
› Further Information
    Permissions and Reprints All articles of this category


Dedicated to Professor Koichi Narasaka in celebration of his 80th birthday (Sanju)

Abstract

A convenient method for synthesizing 1-alkyl-2-acyl-sn-glycero-3-phosphoethanolamines (1-alkyl-2-acyl-GPEs) starting from an optical active alcohol is described. In this method, the phosphate group was introduced through the transesterification that we developed, and a protected 1-alkyl-2-lyso-GPE was employed as an intermediate. This compound is stable and serves as a common intermediate for the synthesis of various 1-alkyl-2-acyl-GPEs with different acyl groups.

Key words

ether phospholipids - glycerophospholipids - phosphoethanolamines - transesterification - phosphorylation

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/a-2257-0684.
  • Supporting Information


Publication History

Received: 26 December 2023

Accepted after revision: 30 January 2024

Accepted Manuscript online:
30 January 2024

Article published online:
20 February 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

    • 2a Kostadinova A, Topouzova-Hristova T, Momchilova A, Tzoneva R, Berger MR. Antitumor Lipids–Structure, Functions, and Medical Applications. In Advances in Protein Chemistry and Structural Biology, Vol. 101. Donev R. Academic Press; London: 2015: 27-66
      Google Scholar
    • 2b van Blitterswijk JW, Verheij M. Curr. Pharm. Des. 2008; 14: 2061
      CrossrefPubMed
  • 3 Paltauf F. Chem. Phys. Lipids 1994; 74: 101
    CrossrefPubMed
  • 4 Marathe GK, Chaithra VH, Ke L.-Y, Chen C.-H. Prostaglandins Other Lipid Mediators 2020; 151: 106478
    CrossrefPubMed
    • 5a Zhu G, Alhamhoom Y, Cummings BS, Arnold RD. Bioorg. Med. Chem. Lett. 2011; 21: 6370
      CrossrefPubMed
    • 5b Derksen JT, Baldeschwieler JD, Scherphof GL. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 9768
      CrossrefPubMed
    • 6a Wichmann O, Gelb MH, Schultz C. ChemBioChem 2007; 8: 1555
      CrossrefPubMed
    • 6b Peters GH, Møller MS, Jørgensen K, Rönnholm P, Mikkelsen M, Andresen TL. J. Am. Chem. Soc. 2007; 129: 5451
      CrossrefPubMed
    • 6c Moghimi SM, Hamad I, Andresen TL, Jørgensen K, Szebeni J. FASEB J. 2006; 20: 2591
      CrossrefPubMed
    • 6d Spyvee MR, Zhang H, Hawkins LD, Chow JC. Bioorg. Med. Chem. Lett. 2005; 15: 5494
      CrossrefPubMed
    • 6e Xia J, Hui Y.-Z. Tetrahedron: Asymmetry 1997; 8: 3131
      Crossref
    • 7a Tsubaki K, Yamanaka T, Hisamitsu T, Shimooka H, Kitamura M, Okauchi T. Synthesis 2021; 53: 3827
      Article in Thieme Connect
    • 7b Tsubaki K, Shimooka H, Kitamura M, Okauchi T. Org. Lett. 2019; 21: 9779
      CrossrefPubMed
  • 8 Purification of Laboratory Chemicals, 5th ed. Armarego WL. F, Chai CL. L. Butterworth-Heinemann; London: 2002
    Google Scholar
  • 9 Tsubaki K. Development and applications of a new synthetic method for the synthesis of organophosphate. Kyushu Institute of Technology, Faculty of Engineering, Department of Applied Chemistry, Ph.D. Thesis, Kitakyushu (Japan), 2021, https://kyutech.repo.nii.ac.jp/records/7134.
  • 10 Gil-Mesón A, Roncero AM, Tobal IE, Basabe P, Díez D, Mollinedo F, Marcos IS. Molecules 2016; 21: 47
    CrossrefPubMed